FDA Investigating Everest, MDH Masalas For Cancer-Causing Pesticide

India-West News Desk

WASHINGTON, DC – The US Food and Drug Administration (FDA) has initiated an investigation into the composition of spice blends produced by two Indian companies amid claims of high levels of cancer-causing pesticides. Earlier this month, Hong Kong took action by suspending the sale of three spice mixes from MDH and one from Everest due to alleged contamination with ethylene oxide, a hazardous substance, the BBC said.

According to Reuters, the FDA is actively reviewing the reports of potential health risks associated with these spice mixes. A spokesperson for the agency stated that they are currently gathering additional information about the situation.

Hindustan Times reported that Everest, one of the companies involved, has asserted the safety of its products for consumption. In response to the allegations, the company stated that its spices are exported only after undergoing necessary clearances and approvals from Indian Spice Board laboratories.

On the other hand, MDH has refuted the allegations, describing them as baseless and lacking substantiating evidence. This is not the first time MDH has faced scrutiny. In 2019, batches of its sambar powder were recalled due to salmonella contamination.

The Indian Spice Board, responsible for overseeing spice exports, has also intervened in the matter. It has requested export data from authorities in Hong Kong and Singapore and is collaborating with the companies to investigate the root cause of the alleged quality issues. Inspections have commenced at the respective plants to ensure compliance with regulatory standards.